Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway.

Yang, Jin-Yu; Tao, Li-Jun; Liu, Bei; You, Xin-Yi; Zhang, Chao-Feng; Xie, Hai-Feng; Li, Ren-Shi

Yang, Jin-Yu; Tao, Li-Jun; Liu, Bei; You, Xin-Yi; Zhang, Chao-Feng; Xie, Hai-Feng; Li, Ren-Shi.

Afiliación

Yang JY; State Key Laboratory of Natural Medicines, School of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing, China.
Tao LJ; State Key Laboratory of Natural Medicines, School of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing, China.
Liu B; State Key Laboratory of Natural Medicines, School of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing, China.
You XY; State Key Laboratory of Natural Medicines, School of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing, China.
Zhang CF; State Key Laboratory of Natural Medicines, School of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing, China.
Xie HF; Chengdu Biopurify Phytochemicals Ltd., Chengdu, China.
Li RS; State Key Laboratory of Natural Medicines, School of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing, China.

Front Pharmacol ; 10: 151, 2019.

Article en En | MEDLINE | ID: mdl-30890932

Palabras clave

AMPK; Eclipta prostrata; bleomycin; pulmonary fibrosis; wedelolactone

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google